More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

CrowdStrike to buy identity security startup SGNL for $740 million to tackle AI threats CrowdStrike said on Thursday it would buy identity security startup SGNL in a deal valued at $740 million aiming ...